Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH4 MYH6 MYH7	2.84e-06	38	118	5	GO:0000146
GeneOntologyMolecularFunction	ATP-dependent activity	MYH1 MYH2 MYH4 MYH6 MYH7 HYOU1 DHX37 CHD8 CPOX DNAI2 DDX23 HSPA6 DDX11L8 HELLS	1.60e-05	614	118	14	GO:0140657
GeneOntologyMolecularFunction	SUMO-modified protein reader activity	DAXX PML	3.46e-05	2	118	2	GO:0140037
GeneOntologyMolecularFunction	protein domain specific binding	VAPB HIVEP1 RARA KHDRBS2 CASP5 CHD8 MECP2 GRIP1 OSBP KHDRBS3 UBR5 TJP1 PIK3R1 ERC2 CDC5L QKI	5.70e-05	875	118	16	GO:0019904
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH4 MYH6 MYH7 DNAI2	7.21e-05	118	118	6	GO:0003774
GeneOntologyMolecularFunction	transcription coregulator activity	TCERG1L NOC2L ASCC1 DAXX KMT2E MECP2 ARID5A RCOR2 ARRB1 MED27 QKI PML	1.25e-04	562	118	12	GO:0003712
GeneOntologyMolecularFunction	cytoskeletal protein binding	VAPB MYH1 MYH2 MYH4 MYH6 MYH7 RARA MARK1 MYRIP DAXX FAM161A MARK4 DIAPH1 LMOD1 DAAM1 TNNT1 TTLL13	2.50e-04	1099	118	17	GO:0008092
GeneOntologyMolecularFunction	molecular adaptor activity	RNF169 TCERG1L NOC2L ASCC1 DAXX KMT2E MECP2 ARID5A RCOR2 GRIP1 ARRB1 PIK3R1 MARK4 TPX2 OTUD4 MED27 QKI HDGFL2 PML	3.68e-04	1356	118	19	GO:0060090
GeneOntologyMolecularFunction	ubiquitin-like protein reader activity	RNF169 DAXX PML	4.21e-04	25	118	3	GO:0140035
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH4 MYH6 MYH7 TJP1 PIK3R1	4.38e-04	230	118	7	GO:0005516
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	RNF169 TCERG1L NOC2L ASCC1 DAXX KMT2E MECP2 ARID5A RCOR2 GRIP1 ARRB1 PIK3R1 MARK4 MED27 QKI HDGFL2 PML	4.66e-04	1160	118	17	GO:0030674
GeneOntologyMolecularFunction	histone reader activity	RNF169 MECP2 HDGFL2	4.74e-04	26	118	3	GO:0140566
GeneOntologyMolecularFunction	beta-catenin binding	CHD8 GRIP1 RNF220 TJP1 PROP1	7.34e-04	120	118	5	GO:0008013
GeneOntologyMolecularFunction	modification-dependent protein binding	RNF169 DAXX CHD8 KMT2E HDGFL2 PML	1.42e-03	206	118	6	GO:0140030
GeneOntologyMolecularFunction	chromatin-protein adaptor activity	RNF169 MECP2 HDGFL2	1.82e-03	41	118	3	GO:0140463
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 MYH4 MYH6 MYH7 MYRIP DIAPH1 LMOD1 DAAM1	2.17e-03	479	118	9	GO:0003779
GeneOntologyMolecularFunction	transcription coactivator activity	ASCC1 DAXX KMT2E ARRB1 MED27 QKI PML	2.17e-03	303	118	7	GO:0003713
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH4 MYH6 MYH7	1.19e-06	15	115	4	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH4 MYH6 MYH7	2.64e-06	18	115	4	GO:0033275
GeneOntologyBiologicalProcess	actin filament-based process	MYH2 MYH4 MYH6 MYH7 ASAP3 MYRIP CASP5 ARHGEF11 ARRB1 TJP1 PIK3R1 DIAPH1 LMOD1 DAAM1 GRHL3 TNNT1 QKI BAIAP2L2	2.93e-06	912	115	18	GO:0030029
GeneOntologyBiologicalProcess	muscle cell differentiation	MYH6 MYH7 RARA RARB SGCB DAXX MECP2 ALPK3 LMOD1 C3 TNNT1 QKI HDGFL2	8.39e-06	531	115	13	GO:0042692
GeneOntologyBiologicalProcess	actomyosin structure organization	MYH6 MYH7 ASAP3 ARRB1 TJP1 PIK3R1 LMOD1 TNNT1	5.89e-05	239	115	8	GO:0031032
GeneOntologyBiologicalProcess	slow-twitch skeletal muscle fiber contraction	MYH7 TNNT1	9.21e-05	3	115	2	GO:0031444
GeneOntologyBiologicalProcess	positive regulation of protein acetylation	ARID5A FAM161A PML	1.30e-04	18	115	3	GO:1901985
GeneOntologyBiologicalProcess	actin cytoskeleton organization	MYH6 MYH7 ASAP3 CASP5 ARHGEF11 ARRB1 TJP1 PIK3R1 DIAPH1 LMOD1 DAAM1 GRHL3 TNNT1 BAIAP2L2	1.53e-04	803	115	14	GO:0030036
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH4 MYH6 MYH7	2.59e-08	16	122	5	GO:0005859
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH4 MYH6 MYH7	3.02e-07	25	122	5	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH4 MYH6 MYH7	5.50e-07	28	122	5	GO:0016460
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH4 MYH6 MYH7	2.43e-05	59	122	5	GO:0016459
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH2 MYH4 MYH6 MYH7 RARA MYRIP TJP1 DIAPH1 LMOD1 DAAM1 TNNT1	1.41e-04	576	122	12	GO:0015629
GeneOntologyCellularComponent	supramolecular fiber	MYH1 MYH2 MYH4 MYH6 MYH7 IFFO1 CEP162 DAXX NCKAP5 ODF2 GRIP1 FAM161A DNAI2 TPX2 DIAPH1 LMOD1 TNNT1 TTLL13	1.66e-04	1179	122	18	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	MYH1 MYH2 MYH4 MYH6 MYH7 IFFO1 CEP162 DAXX NCKAP5 ODF2 GRIP1 FAM161A DNAI2 TPX2 DIAPH1 LMOD1 TNNT1 TTLL13	1.80e-04	1187	122	18	GO:0099081
GeneOntologyCellularComponent	chromatin	RARA RARB NOC2L DAXX CHD8 SIM1 KMT2E MECP2 TFCP2 RCOR2 TFCP2L1 ARRB1 UBR5 UBP1 NFIL3 DDX23 GRHL3 DDX11L8 PROP1 HELLS	3.52e-04	1480	122	20	GO:0000785
GeneOntologyCellularComponent	sarcomere	MYH1 MYH2 MYH4 MYH6 MYH7 LMOD1 TNNT1	6.55e-04	249	122	7	GO:0030017
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 MYH4 MYH6 MYH7 LMOD1 TNNT1	1.12e-03	273	122	7	GO:0030016
MousePheno	increased allantois apoptosis	DAXX TJP1 DDX11L8	1.56e-05	8	93	3	MP:0003891
Domain	CP2	TFCP2 TFCP2L1 UBP1 GRHL3	2.33e-08	6	119	4	PF04516
Domain	CP2	TFCP2 TFCP2L1 UBP1 GRHL3	2.33e-08	6	119	4	IPR007604
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH7	2.75e-08	15	119	5	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH4 MYH6 MYH7	2.75e-08	15	119	5	IPR004009
Domain	Myosin_tail_1	MYH1 MYH2 MYH4 MYH6 MYH7	7.74e-08	18	119	5	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH4 MYH6 MYH7	7.74e-08	18	119	5	IPR002928
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH4 MYH6 MYH7	1.04e-07	19	119	5	IPR027401
Domain	-	MYH1 MYH2 MYH4 MYH6 MYH7	1.04e-07	19	119	5	4.10.270.10
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH4 MYH6 MYH7	4.09e-06	38	119	5	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH4 MYH6 MYH7	4.09e-06	38	119	5	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH4 MYH6 MYH7	4.09e-06	38	119	5	PF00063
Domain	KH_1	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	4.09e-06	38	119	5	PF00013
Domain	MYSc	MYH1 MYH2 MYH4 MYH6 MYH7	4.09e-06	38	119	5	SM00242
Domain	-	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	4.67e-06	39	119	5	3.30.1370.10
Domain	KH	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	5.31e-06	40	119	5	SM00322
Domain	KH_dom	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	5.31e-06	40	119	5	IPR004087
Domain	KH_TYPE_1	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	6.80e-06	42	119	5	PS50084
Domain	KH_dom_type_1	KHDRBS2 ASCC1 KHDRBS3 QKI HDLBP	8.59e-06	44	119	5	IPR004088
Domain	TCEAL1	TCEAL3 TCEAL2 TCEAL6	2.06e-05	9	119	3	IPR010370
Domain	TF_A-like/BEX	TCEAL3 TCEAL2 TCEAL6	8.72e-05	14	119	3	IPR021156
Domain	BEX	TCEAL3 TCEAL2 TCEAL6	8.72e-05	14	119	3	PF04538
Domain	Qua1	KHDRBS2 KHDRBS3	1.20e-04	3	119	2	PF16274
Domain	Qua1_dom	KHDRBS2 KHDRBS3	1.20e-04	3	119	2	IPR032571
Domain	Sam68-YY	KHDRBS2 KHDRBS3	1.20e-04	3	119	2	IPR032335
Domain	RGS-like	ARHGEF11 ARHGEF1	1.20e-04	3	119	2	PF09128
Domain	RGS-like_dom	ARHGEF11 ARHGEF1	1.20e-04	3	119	2	IPR015212
Domain	Sam68-YY	KHDRBS2 KHDRBS3	1.20e-04	3	119	2	PF16568
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH7	1.68e-04	81	119	5	SM00015
Domain	MARK/par1	MARK1 MARK4	2.40e-04	4	119	2	IPR033624
Domain	Retinoic_acid_rcpt	RARA RARB	2.40e-04	4	119	2	IPR003078
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH4 MYH6 MYH7	2.75e-04	90	119	5	IPR000048
Domain	IQ	MYH1 MYH2 MYH4 MYH6 MYH7	3.21e-04	93	119	5	PS50096
Domain	KA1_dom	MARK1 MARK4	3.98e-04	5	119	2	IPR001772
Domain	KA1	MARK1 MARK4	3.98e-04	5	119	2	PF02149
Domain	KA1	MARK1 MARK4	3.98e-04	5	119	2	PS50032
Domain	-	MARK1 MARK4	3.98e-04	5	119	2	3.30.310.80
Domain	KA1/Ssp2_C	MARK1 MARK4	8.28e-04	7	119	2	IPR028375
Domain	IQ	MYH1 MYH2 MYH4 MYH6	1.10e-03	71	119	4	PF00612
Domain	DAD_dom	DIAPH1 DAAM1	1.10e-03	8	119	2	IPR014767
Domain	DAD	DIAPH1 DAAM1	1.10e-03	8	119	2	PS51231
Domain	Drf_GBD	DIAPH1 DAAM1	1.41e-03	9	119	2	PF06371
Domain	FH3_dom	DIAPH1 DAAM1	1.41e-03	9	119	2	IPR010472
Domain	GTPase-bd	DIAPH1 DAAM1	1.41e-03	9	119	2	IPR010473
Domain	Drf_FH3	DIAPH1 DAAM1	1.41e-03	9	119	2	PF06367
Domain	Drf_FH3	DIAPH1 DAAM1	1.41e-03	9	119	2	SM01139
Domain	Drf_GBD	DIAPH1 DAAM1	1.41e-03	9	119	2	SM01140
Domain	GBD/FH3_dom	DIAPH1 DAAM1	2.13e-03	11	119	2	IPR014768
Domain	ARM-rpt_dom	GPRASP1 ARMCX3	2.13e-03	11	119	2	IPR006911
Domain	Arm_2	GPRASP1 ARMCX3	2.13e-03	11	119	2	PF04826
Domain	GBD_FH3	DIAPH1 DAAM1	2.13e-03	11	119	2	PS51232
Domain	-	HYOU1 HSPA6	2.55e-03	12	119	2	2.60.34.10
Domain	HSP70_peptide-bd	HYOU1 HSPA6	2.55e-03	12	119	2	IPR029047
Domain	-	HYOU1 HSPA6	3.00e-03	13	119	2	1.20.1270.10
Domain	Heat_shock_70_CS	HYOU1 HSPA6	3.00e-03	13	119	2	IPR018181
Domain	HSP70_C	HYOU1 HSPA6	3.00e-03	13	119	2	IPR029048
Domain	FH2	DIAPH1 DAAM1	4.00e-03	15	119	2	PS51444
Domain	FH2_Formin	DIAPH1 DAAM1	4.00e-03	15	119	2	IPR015425
Domain	FH2	DIAPH1 DAAM1	4.00e-03	15	119	2	PF02181
Domain	FH2	DIAPH1 DAAM1	4.00e-03	15	119	2	SM00498
Domain	HSP70	HYOU1 HSPA6	4.56e-03	16	119	2	PF00012
Domain	Helicase_C	DHX37 CHD8 DDX23 HELLS	4.88e-03	107	119	4	PF00271
Domain	HELICc	DHX37 CHD8 DDX23 HELLS	4.88e-03	107	119	4	SM00490
Domain	Helicase_C	DHX37 CHD8 DDX23 HELLS	5.05e-03	108	119	4	IPR001650
Domain	HSP70_2	HYOU1 HSPA6	5.14e-03	17	119	2	PS00329
Domain	HSP70_3	HYOU1 HSPA6	5.14e-03	17	119	2	PS01036
Domain	HSP70_1	HYOU1 HSPA6	5.14e-03	17	119	2	PS00297
Domain	HELICASE_CTER	DHX37 CHD8 DDX23 HELLS	5.21e-03	109	119	4	PS51194
Domain	HELICASE_ATP_BIND_1	DHX37 CHD8 DDX23 HELLS	5.21e-03	109	119	4	PS51192
Domain	DEXDc	DHX37 CHD8 DDX23 HELLS	5.21e-03	109	119	4	SM00487
Domain	Helicase_ATP-bd	DHX37 CHD8 DDX23 HELLS	5.38e-03	110	119	4	IPR014001
Domain	Hsp_70_fam	HYOU1 HSPA6	5.76e-03	18	119	2	IPR013126
Pathway	REACTOME_RHOC_GTPASE_CYCLE	VAPB ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	5.06e-06	70	89	6	MM15597
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH2 MYH4 MYH6 MYH7 SGCB	5.06e-06	70	89	6	M12294
Pathway	REACTOME_RHOC_GTPASE_CYCLE	VAPB ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	7.01e-06	74	89	6	M41807
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	7.32e-05	69	89	5	MM15596
Pathway	REACTOME_RHOB_GTPASE_CYCLE	ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	7.85e-05	70	89	5	M41806
Pathway	BIOCARTA_PML_PATHWAY	RARA DAXX PML	1.55e-04	17	89	3	M4891
Pathway	KEGG_TIGHT_JUNCTION	MYH1 MYH2 MYH4 MYH6 MYH7 TJP1	1.85e-04	132	89	6	M11355
Pathway	BIOCARTA_PML_PATHWAY	RARA DAXX PML	1.85e-04	18	89	3	MM1474
Pathway	REACTOME_RHOA_GTPASE_CYCLE	VAPB ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	2.75e-04	142	89	6	MM15576
Pathway	BIOCARTA_RHO_PATHWAY	ARHGEF11 ARHGEF1 DIAPH1	2.98e-04	21	89	3	M1001
Pathway	REACTOME_RHOA_GTPASE_CYCLE	VAPB ARHGEF11 PIK3R1 ARHGEF1 DIAPH1 DAAM1	3.56e-04	149	89	6	M41805
Pathway	REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING	KHDRBS2 KHDRBS3	3.89e-04	5	89	2	M27731
Pathway	REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING	KHDRBS2 KHDRBS3	3.89e-04	5	89	2	MM15481
Pathway	WP_VITAMIN_A1_AND_A5X_PATHWAYS	RARA RARB	5.82e-04	6	89	2	M48097
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	VAPB MYH1 MYH2 MYH4 MYH6 MYH7 TCERG1L HYOU1 CCDC185 NOC2L KHDRBS2 MYRIP HKDC1 ZNF318 CPOX ODF2 MECP2 ARRB1 KHDRBS3 TJP1 CCDC47 RRS1 FAM161A DDX23 ERC2 TNNT1 HDGFL2 HSPA6	1.32e-13	1442	123	28	35575683
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH4 MYH6 MYH7	1.06e-11	7	123	5	16819597
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	GPRASP1 MYH1 MYH2 MYH4 MYH7	6.35e-11	9	123	5	31960486
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	VAPB HYOU1 UACA NOC2L ZC3H15 RALGAPB ASCC1 CC2D1A TFCP2 PPP2R5D UBR5 CCDC47 RRS1 PIK3R1 DDX23 DAAM1 CDC5L TIMM44 HDGFL2 HSPA6 RBM34 PML HDLBP HELLS	4.16e-10	1487	123	24	33957083
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	RNF169 UACA NOC2L ZC3H15 RALGAPB ASCC1 DAXX CHD8 ZNF318 ODF2 ARHGEF11 MECP2 ARRB1 CCDC47 RRS1 UBP1 TPX2 OTUD4 DAAM1 MED27 CCDC86 HDGFL2 HSPA6 HDLBP	4.75e-10	1497	123	24	31527615
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4 MYH7	7.43e-10	5	123	4	12919077
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH4 MYH7 TNNT1	9.95e-10	14	123	5	27184118
Pubmed	Loss of Prox1 in striated muscle causes slow to fast skeletal muscle fiber conversion and dilated cardiomyopathy.	MYH1 MYH2 MYH4 MYH6 MYH7	9.95e-10	14	123	5	24938781
Pubmed	Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6.	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	1.18e-09	31	123	6	21985497
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 MYH2 MYH4 MYH7 TNNT1	1.49e-09	15	123	5	24852826
Pubmed	A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance.	MYH1 MYH2 MYH4 MYH6 MYH7	2.16e-09	16	123	5	19922871
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH4 MYH7	2.22e-09	6	123	4	1728586
Pubmed	Identification and characterization of Grainyhead-like epithelial transactivator (GET-1), a novel mammalian Grainyhead-like factor.	TFCP2 TFCP2L1 UBP1 GRHL3	2.22e-09	6	123	4	12666198
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH4 MYH7	2.22e-09	6	123	4	10588881
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	UACA RALGAPB ASCC1 ARCN1 MRPL16 TJP1 CCDC47 ARHGEF1 OTUD4 C3 TIMM44 CCDC86 HDGFL2 HDLBP HELLS	3.88e-09	601	123	15	33658012
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	HYOU1 ZC3H15 CC2D1A ARMCX3 ARCN1 RTF1 ARRB1 PPP2R5D UBR5 TJP1 CCDC47 ARHGEF1 DIAPH1 DDX23 CDC5L SNRPA TIMM44 CCDC86 HDGFL2 HSPA6 HDLBP HELLS	4.89e-09	1415	123	22	28515276
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH4 MYH7	5.17e-09	7	123	4	35210422
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH4 MYH7	5.17e-09	7	123	4	29758057
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	RNF169 DAXX CHD8 ZNF318 TFCP2 RNF220 TJP1 ERC2 CDC5L HSPA6 PML HDLBP HELLS	6.92e-09	444	123	13	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RNF169 HIVEP1 RARA ZC3H15 CHD8 ZNF318 MECP2 TJP1 RRS1 TPX2 ZNF808 CDC5L SNRPA CCDC86 HDGFL2 PML HDLBP HELLS	7.74e-09	954	123	18	36373674
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4 MYH6	1.03e-08	8	123	4	14667415
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4 MYH7	1.03e-08	8	123	4	26993635
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH4 MYH6 MYH7	1.03e-08	8	123	4	3864153
Pubmed	Mammalian BEX, WEX and GASP genes: coding and non-coding chimaerism sustained by gene conversion events.	GPRASP1 TCEAL3 TCEAL2 ARMCX3 TCEAL6	2.05e-08	24	123	5	16221301
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	4.32e-08	3	123	3	26059207
Pubmed	The expression of myosin heavy chain (MHC) genes in human skeletal muscle is related to metabolic characteristics involved in the pathogenesis of type 2 diabetes.	MYH1 MYH2 MYH7	4.32e-08	3	123	3	21470888
Pubmed	Structural and developmental analysis of two linked myosin heavy chain genes.	MYH1 MYH2 MYH7	4.32e-08	3	123	3	1371481
Pubmed	TFCP2/TFCP2L1/UBP1 transcription factors in cancer.	TFCP2 TFCP2L1 UBP1	4.32e-08	3	123	3	29410248
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4 MYH7	4.82e-08	11	123	4	18310078
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH4 MYH7	4.82e-08	11	123	4	16024798
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4 MYH7	4.82e-08	11	123	4	29168801
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	NOC2L CC2D1A DAXX CHD8 MECP2 ARRB1 C1orf226 RRS1 TPX2 DDX23 MED27 CCDC86 HELLS	5.89e-08	533	123	13	30554943
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	VAPB HYOU1 NOC2L IFFO1 DHX37 CEP162 CC2D1A ODF2 ARHGEF11 TFCP2 ARCN1 GRIP1 PPP2R5D UBR5 TJP1 TIMM44	6.13e-08	853	123	16	28718761
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	HIVEP1 RARA HYOU1 ZC3H15 CC2D1A CHD8 ZNF318 MECP2 UBR5 NFIL3 TPX2 DDX23 SNRPA MED27 QKI PML HDLBP HELLS	6.98e-08	1103	123	18	34189442
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VAPB UACA DHX37 CC2D1A MECP2 TFCP2 ARCN1 KHDRBS3 TJP1 CCDC47 RRS1 TPX2 OTUD4 DDX23 MED27 QKI TIMM44 CCDC86 RBM34 HDLBP	7.55e-08	1371	123	20	36244648
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	VAPB GPRASP1 MYH2 MYH4 HIVEP1 MARK1 TCEAL2 ARCN1 USP20 RNF220 UBR5 TJP1 MARK4 OTUD4 DDX23 QKI DCAF4	1.01e-07	1005	123	17	19615732
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH4 MYH7	1.04e-07	13	123	4	8404542
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	MYH2 MYH4 MYH7 HYOU1 NOC2L DHX37 CEP162 RTF1 ARRB1 UBR5 CCDC47 PIK3R1 OTUD4 DDX23 CDC5L SNRPA HDGFL2 HDLBP HELLS	1.33e-07	1284	123	19	17353931
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	VAPB HIVEP1 HYOU1 NOC2L ZC3H15 DHX37 LAMC3 CPOX TFCP2 ARCN1 CCDC47 RRS1 DIAPH1 CDC5L SNRPA TIMM44 CCDC86 RBM34 HDLBP HELLS	1.40e-07	1425	123	20	30948266
Pubmed	Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation.	MYH1 MYH2 MYH4 MYH7	1.45e-07	14	123	4	33742095
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	1.72e-07	4	123	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	1.72e-07	4	123	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	1.72e-07	4	123	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	1.72e-07	4	123	3	11023856
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	GPRASP1 HIVEP1 UACA CEP162 UBXN6 CC2D1A LAMC3 DAXX RNF220 ARRB1 ARHGEF1 DDX23 EBAG9 QKI PML HELLS	1.83e-07	925	123	16	28986522
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	VAPB RNF169 HYOU1 CEP162 RALGAPB ODF2 PPP2R5D C1orf226 TJP1 CCDC47 PIK3R1 OTUD4 CDC5L CCDC86 HSPA6 HDLBP HELLS	1.84e-07	1049	123	17	27880917
Pubmed	MusTRD can regulate postnatal fiber-specific expression.	MYH1 MYH2 MYH4 TNNT1	2.62e-07	16	123	4	16494860
Pubmed	IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism.	MYH1 MYH2 MYH4 MYH7	3.42e-07	17	123	4	22351927
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH2 MYH4 MYH7 TNNT1	3.42e-07	17	123	4	16124007
Pubmed	In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.	VAPB NOC2L ZC3H15 DHX37 ASCC1 ARCN1 UBR5 ERC2 CDC5L SNRPA QKI TIMM44 HSPA6 RBM34 HDLBP HELLS	3.51e-07	971	123	16	33306668
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH4	4.29e-07	5	123	3	3829126
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	4.29e-07	5	123	3	30737693
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH4	4.29e-07	5	123	3	6196357
Pubmed	Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice.	MYH1 MYH2 MYH7	4.29e-07	5	123	3	17584907
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	VAPB HYOU1 ZC3H15 DHX37 LAMC3 PPP2R5D UBR5 TJP1 CCDC47 ARHGEF1 TPX2 DIAPH1 C3 SNRPA CCDC86 HSPA6 RBM34 HELLS	7.47e-07	1297	123	18	33545068
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	8.57e-07	6	123	3	20417199
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH4	8.57e-07	6	123	3	10077619
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	8.57e-07	6	123	3	17559643
Pubmed	Sam68 RNA binding protein is an in vivo substrate for protein arginine N-methyltransferase 1.	KHDRBS2 KHDRBS3 QKI	8.57e-07	6	123	3	12529443
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH2 MYH4 MYH6	1.04e-06	22	123	4	24301466
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	MARK1 ZC3H15 DHX37 KHDRBS2 SIM1 MECP2 RCOR2 KHDRBS3 MRPL16 TJP1 RRS1 DDX23 CDC5L SNRPA CCDC86 HSPA6	1.45e-06	1082	123	16	38697112
Pubmed	The brain expressed x-linked gene 1 (Bex1) regulates myoblast fusion.	MYH1 MYH2 MYH7	1.50e-06	7	123	3	26586200
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	RNF169 HIVEP1 DHX37 DAXX CHD8 MECP2 RNF220 TPX2 CCDC86 HDGFL2 RBM34 HELLS	1.81e-06	608	123	12	36089195
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	HYOU1 UACA ZC3H15 DHX37 ASCC1 CC2D1A DAXX TFCP2 TJP1 RRS1 OTUD4 HDLBP HELLS	1.87e-06	724	123	13	36232890
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	MYH1 MYH2 MYH4 MYH7 TNNT1	2.01e-06	58	123	5	21884692
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	HYOU1 UACA NOC2L ZC3H15 DHX37 ASCC1 MECP2 ARCN1 TJP1 RRS1 TPX2 C3 CDC5L SNRPA RBM34 PML HDLBP	2.21e-06	1257	123	17	36526897
Pubmed	An Oct4-centered protein interaction network in embryonic stem cells.	TFCP2 RCOR2 TFCP2L1 UBP1 MED27 PML HELLS	2.31e-06	167	123	7	20362541
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	2.39e-06	8	123	3	33667029
Pubmed	POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.	POTEB3 POTED POTEC	2.39e-06	8	123	3	12475935
Pubmed	A 1.1-Mb segmental deletion on the X chromosome causes meiotic failure in male mice.	GPRASP1 TCEAL3 ARMCX3 TCEAL6	2.86e-06	28	123	4	23677977
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	VAPB MYH1 MYH2 MYH4 MYH6 MYH7 HYOU1 ARCN1 UBR5 C3 DAAM1 SNRPA	3.41e-06	647	123	12	26618866
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	HYOU1 NOC2L DHX37 CHD8 ZNF318 UBR5 TJP1 RRS1 DDX23 CCDC86 RBM34 HDLBP	3.75e-06	653	123	12	22586326
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RNF169 HIVEP1 UACA RALGAPB DAXX ZNF318 ODF2 MECP2 OSBP TPX2 OTUD4 CCDC86 HDLBP	3.86e-06	774	123	13	15302935
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	UACA NOC2L ARHGEF11 TFCP2 TJP1 UBP1 DDX23 CDC5L SNRPA CCDC86 HDGFL2 PML	4.18e-06	660	123	12	32780723
Pubmed	Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.	MYH1 MYH2 MYH4 MYH7	4.35e-06	31	123	4	30081710
Pubmed	Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.	VAPB RNF169 NOC2L ARHGEF11 MECP2 ARCN1 MRPL16 CCDC47 RRS1 PIK3R1 ARHGEF1 TPX2 SNRPA CCDC86	4.74e-06	916	123	14	32203420
Pubmed	Topoisomerase IIbeta negatively modulates retinoic acid receptor alpha function: a novel mechanism of retinoic acid resistance.	RARA RARB PML	5.09e-06	10	123	3	18212063
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH1 MYH2 MYH4 MYH7	5.63e-06	33	123	4	32094117
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	NOC2L DHX37 CHD8 ARCN1 UBR5 CCDC47 RRS1 ARHGEF1 DIAPH1 DDX23 CDC5L SNRPA TIMM44 CCDC86 HSPA6 RBM34 HDLBP	5.88e-06	1353	123	17	29467282
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	VAPB ZC3H15 CC2D1A ZNF318 TFCP2 ARCN1 TJP1 RRS1 TPX2 CDC5L HDGFL2 PML HDLBP HELLS	5.92e-06	934	123	14	33916271
Pubmed	CAP2 deficiency delays myofibril actin cytoskeleton differentiation and disturbs skeletal muscle architecture and function.	MYH2 MYH4 MYH7	6.98e-06	11	123	3	30962377
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4	6.98e-06	11	123	3	8136524
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	6.98e-06	11	123	3	38303699
Pubmed	Ephrin-A3 promotes and maintains slow muscle fiber identity during postnatal development and reinnervation.	MYH2 MYH4 MYH7	6.98e-06	11	123	3	26644518
Pubmed	Transcription factor Foxp3 and its protein partners form a complex regulatory network.	NOC2L DHX37 CHD8 ARCN1 ARHGEF1 CDC5L SNRPA QKI RBM34	7.18e-06	370	123	9	22922362
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	CHD8 ARCN1 ARHGEF1 TPX2 DIAPH1 DDX23 CDC5L SNRPA HSPA6 HDLBP HELLS	7.46e-06	582	123	11	20467437
Pubmed	A human MAP kinase interactome.	HIVEP1 DAXX CHD8 NCKAP5 ARHGEF11 RTKN2 ARRB1 PIK3R1 ARHGEF1 HDLBP	9.50e-06	486	123	10	20936779
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH1 MYH2 MYH4 MED27	1.11e-05	39	123	4	38690566
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	NOC2L DAXX CHD8 TJP1 TPX2 DDX23 CDC5L SNRPA CCDC86	1.19e-05	394	123	9	27248496
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	VAPB RNF169 HYOU1 PPP2R5D TJP1 CCDC47 RRS1 TPX2 DIAPH1 CDC5L MED27 TIMM44	1.20e-05	733	123	12	34672954
Pubmed	TAF7L modulates brown adipose tissue formation.	MYH1 MYH4 MYH6	1.20e-05	13	123	3	24876128
Pubmed	Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.	RARA PML	1.24e-05	2	123	2	20155840
Pubmed	Reversible epigenetic modifications of the two cardiac myosin heavy chain genes during changes in expression.	MYH6 MYH7	1.24e-05	2	123	2	21526716
Pubmed	PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.	DAXX PML	1.24e-05	2	123	2	10525530
Pubmed	Retinoic acid receptor alpha fusion to PML affects its transcriptional and chromatin-remodeling properties.	RARA PML	1.24e-05	2	123	2	14612419
Pubmed	Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation.	RARA RARB	1.24e-05	2	123	2	29921692
Pubmed	Myosin heavy chains IIa and IId are functionally distinct in the mouse.	MYH1 MYH2	1.24e-05	2	123	2	9585413
Pubmed	Expression patterns of specific promyelocytic/retinoic acid receptor-alpha transcripts in patients with acute promyelocytic leukemia.	RARA PML	1.24e-05	2	123	2	19863682
Pubmed	Promyelocytic leukemia protein (PML) and Daxx participate in a novel nuclear pathway for apoptosis.	DAXX PML	1.24e-05	2	123	2	10684855
Pubmed	Microarray, gene sequencing, and reverse transcriptase-polymerase chain reaction analyses of a cryptic PML-RARA translocation.	RARA PML	1.24e-05	2	123	2	22982005
Interaction	NOLC1 interactions	STK17A CC2D1A DAXX MECP2 ARCN1 ARRB1 UBR5 RRS1 PIK3R1 DDX23 CDC5L PML	6.72e-07	325	122	12	int:NOLC1
Interaction	POTED interactions	POTEB3 POTED POTEC	8.62e-07	4	122	3	int:POTED
Interaction	CFAP141 interactions	MYH4 MYH7 KHDRBS3 TJP1 OTUD4 CDC5L	9.89e-07	55	122	6	int:CFAP141
Interaction	ARHGEF19 interactions	RNF169 MECP2 RRS1 TPX2 DAAM1 CCDC86	1.67e-06	60	122	6	int:ARHGEF19
Interaction	HOOK1 interactions	HYOU1 NOC2L DHX37 UBXN6 CC2D1A PPP2R5D UBR5 TJP1 FAM161A CDC5L	2.04e-06	240	122	10	int:HOOK1
Interaction	SMC5 interactions	MYH1 MYH4 RNF169 HIVEP1 RARA ZC3H15 CHD8 ZNF318 MECP2 TJP1 RRS1 TPX2 ZNF808 CDC5L SNRPA CCDC86 HDGFL2 PML HDLBP HELLS	2.32e-06	1000	122	20	int:SMC5
Interaction	SNW1 interactions	RARA DAXX CHD8 ODF2 MECP2 ARCN1 UBR5 ARHGEF1 DIAPH1 DDX23 CDC5L SNRPA TNNT1 HSPA6 PML HDLBP HELLS	2.65e-06	747	122	17	int:SNW1
Interaction	HDAC1 interactions	MYH1 MYH2 MYH4 MYH7 HIVEP1 RARA RARB DAXX CHD8 ZNF318 KMT2E MECP2 TFCP2 RCOR2 GRIP1 TFCP2L1 UBR5 CCDC47 HSPA6 PML HELLS	2.93e-06	1108	122	21	int:HDAC1
Interaction	ASAH2 interactions	MYH1 MYH4 MYH7	4.27e-06	6	122	3	int:ASAH2
Interaction	PPFIA1 interactions	OSBP PPP2R5D FAM161A PIK3R1 ERC2 EBAG9 CDC5L TNNT1 HDLBP	6.27e-06	214	122	9	int:PPFIA1
Interaction	COIL interactions	VAPB RNF169 HIVEP1 NOC2L DAXX CHD8 MECP2 TFCP2 RTF1 DDX23 CDC5L RBM34 HDLBP HELLS	6.44e-06	552	122	14	int:COIL
Interaction	APEX1 interactions	GPRASP1 RNF169 HIVEP1 UACA NOC2L CEP162 UBXN6 CC2D1A LAMC3 DAXX MECP2 RTF1 RNF220 ARRB1 ARHGEF1 TPX2 DDX23 EBAG9 QKI HDGFL2 PML HELLS	7.10e-06	1271	122	22	int:APEX1
Interaction	PAXBP1 interactions	MECP2 UBR5 TPX2 DDX23 CDC5L SNRPA HDLBP	8.94e-06	121	122	7	int:PAXBP1
Interaction	USP7 interactions	POTEB3 GPRASP1 RNF169 RARA TCEAL2 FMR1NB KHDRBS2 DAXX KMT2E MECP2 ARMCX3 POTEC RNF220 OSBP MARK4 TPX2 OTUD4 LMOD1 CDC5L DCAF4 TTLL13 PML	1.18e-05	1313	122	22	int:USP7
Interaction	CEBPA interactions	HIVEP1 RARA RARB HYOU1 NOC2L ZC3H15 CC2D1A CHD8 ZNF318 MECP2 UBR5 NFIL3 TPX2 DDX23 SNRPA MED27 QKI HDGFL2 PML HDLBP HELLS	1.75e-05	1245	122	21	int:CEBPA
Interaction	DHX40 interactions	NOC2L ATXN7L1 ZNF318 RTF1 UBR5 RRS1 DDX23 CDC5L RBM34	2.11e-05	249	122	9	int:DHX40
Interaction	FZR1 interactions	VAPB GPRASP1 NOC2L ZC3H15 DHX37 ASCC1 DAXX CHD8 ARCN1 UBR5 TPX2 ERC2 CDC5L SNRPA QKI TIMM44 HSPA6 RBM34 HDLBP HELLS	2.41e-05	1172	122	20	int:FZR1
Interaction	DKC1 interactions	NOC2L DAXX CHD8 MECP2 ARRB1 UBR5 RRS1 DDX23 DCAF4 RBM34 HDLBP	2.73e-05	393	122	11	int:DKC1
Interaction	SYNCRIP interactions	MYH1 RARA UACA KHDRBS2 MECP2 TFCP2 KHDRBS3 OTUD4 CDC5L SNRPA QKI DCAF4 HSPA6 PML HDLBP	3.07e-05	721	122	15	int:SYNCRIP
Interaction	AKAP17A interactions	MYH4 MYH7 MECP2 UBR5 DDX23 HDLBP	3.08e-05	99	122	6	int:AKAP17A
Interaction	DDX23 interactions	NOC2L MECP2 RTF1 UBR5 RRS1 DDX23 CDC5L SNRPA HDGFL2 RBM34 HDLBP HELLS	3.53e-05	480	122	12	int:DDX23
Interaction	TCERG1 interactions	TCERG1L CHD8 MECP2 DIAPH1 DDX23 SNRPA PML HDLBP	3.83e-05	207	122	8	int:TCERG1
Interaction	PARP1 interactions	RNF169 HIVEP1 RARA RARB HYOU1 NOC2L DHX37 DAXX MECP2 TFCP2 RTF1 RRS1 UBP1 TPX2 OTUD4 CDC5L HDGFL2 RBM34 PML HDLBP HELLS	3.96e-05	1316	122	21	int:PARP1
Interaction	FBXW7 interactions	UACA NOC2L RALGAPB ASCC1 ARCN1 USP20 MRPL16 TJP1 CCDC47 ARHGEF1 OTUD4 DDX23 C3 MED27 TIMM44 CCDC86 HDGFL2 PML HDLBP HELLS	4.02e-05	1215	122	20	int:FBXW7
Interaction	MACROH2A2 interactions	RARA NOC2L MECP2 RRS1 MED27 HDGFL2 RBM34 PML	4.38e-05	211	122	8	int:MACROH2A2
Interaction	PML interactions	RNF169 RARA NOC2L DAXX CHD8 ZNF318 ARMCX3 TFCP2 UBR5 TJP1 RRS1 ERC2 CDC5L HSPA6 PML HDLBP HELLS	4.71e-05	933	122	17	int:PML
Interaction	H3C3 interactions	RNF169 HIVEP1 DHX37 DAXX CHD8 MECP2 RNF220 TPX2 CCDC86 HDGFL2 RBM34 HELLS	4.75e-05	495	122	12	int:H3C3
Interaction	RSPH6A interactions	MYH1 MYH2 MYH4 MYH7	5.15e-05	34	122	4	int:RSPH6A
Interaction	RBBP6 interactions	KMT2E MECP2 KHDRBS3 DDX23 CDC5L SNRPA DCAF4 RBM34	5.17e-05	216	122	8	int:RBBP6
Interaction	GJA1 interactions	VAPB MYH6 MYH7 UACA MARK1 CC2D1A ARCN1 C1orf226 TJP1 CCDC47 PIK3R1 C3 EBAG9	5.35e-05	583	122	13	int:GJA1
Interaction	HNRNPK interactions	RARA KHDRBS2 CPOX MECP2 TFCP2 ARRB1 KHDRBS3 TJP1 RRS1 PIK3R1 MARK4 DIAPH1 CDC5L SNRPA QKI PML	5.70e-05	853	122	16	int:HNRNPK
Interaction	PRKAG2 interactions	MYH1 MYH2 MYH4 MYH6 MYH7	5.75e-05	68	122	5	int:PRKAG2
Interaction	SNRK interactions	MYH1 MYH2 ARCN1 PPP2R5D	5.79e-05	35	122	4	int:SNRK
Interaction	POTEC interactions	POTEB3 POTED POTEC	5.92e-05	13	122	3	int:POTEC
Interaction	TMEM260 interactions	MYH1 MYH4 MYH7	5.92e-05	13	122	3	int:TMEM260
Interaction	HNRNPLL interactions	KHDRBS2 MECP2 UBR5 CDC5L SNRPA QKI HDGFL2	6.12e-05	163	122	7	int:HNRNPLL
Interaction	FOXP3 interactions	NOC2L DHX37 CHD8 TFCP2 ARCN1 UBP1 ARHGEF1 CDC5L SNRPA QKI RBM34	6.43e-05	432	122	11	int:FOXP3
Interaction	PTBP2 interactions	MECP2 KHDRBS3 CDC5L SNRPA QKI	7.58e-05	72	122	5	int:PTBP2
Interaction	RXRA interactions	RARA RARB NT5DC3 ARID5A GRIP1 PIK3R1 PML	7.68e-05	169	122	7	int:RXRA
Interaction	ZSCAN5A interactions	MYH1 MYH4 MYH7 RCOR2	8.05e-05	38	122	4	int:ZSCAN5A
Interaction	PRPF40A interactions	MECP2 UBR5 RRS1 MARK4 DIAPH1 DDX23 DAAM1 CDC5L SNRPA PML HDLBP	8.54e-05	446	122	11	int:PRPF40A
Interaction	HSPB8 interactions	MYH1 MYH2 MYH4 MYH6 UBXN6 TFCP2L1 PML	8.58e-05	172	122	7	int:HSPB8
Interaction	TLE3 interactions	MYH1 MYH2 MYH4 MYH7 HIVEP1 ZNF318 ARCN1 UBR5 OTUD4 QKI	9.80e-05	376	122	10	int:TLE3
Interaction	CENPA interactions	RNF169 HIVEP1 DHX37 MECP2 RTF1 CCDC47 DIAPH1 HDGFL2 RBM34 HELLS	1.00e-04	377	122	10	int:CENPA
Interaction	VIM interactions	RARA UACA IFFO1 CC2D1A MECP2 TFCP2 ARCN1 ARRB1 UBR5 TJP1 FAM161A CDC5L TNNT1 PML HDLBP	1.05e-04	804	122	15	int:VIM
Interaction	NPM1 interactions	MYH7 HIVEP1 RARA NOC2L ZC3H15 DHX37 CHD8 MECP2 ARMCX3 OSBP ARRB1 RRS1 PIK3R1 DDX23 LMOD1 CCDC86 DCAF4 RBM34 PML	1.08e-04	1201	122	19	int:NPM1
Interaction	PPIG interactions	CHD8 MECP2 TFCP2 TPX2 DDX23 SNRPA	1.24e-04	127	122	6	int:PPIG
Interaction	RPS16 interactions	RARA ZC3H15 DHX37 ASCC1 DAXX MECP2 TFCP2 USP20 CCDC47 RRS1 DDX23 CDC5L CCDC86 HDLBP	1.25e-04	724	122	14	int:RPS16
Interaction	CDK11B interactions	UBXN6 KMT2E MECP2 RTF1 DNAI2 TPX2 HDGFL2	1.26e-04	183	122	7	int:CDK11B
Interaction	PRR3 interactions	DHX37 KHDRBS2 DAXX KHDRBS3 MRPL16 SNRPA QKI CCDC86	1.28e-04	246	122	8	int:PRR3
Interaction	SNRNP40 interactions	HIVEP1 RARA ZNF318 MECP2 UBR5 RRS1 DDX23 CDC5L SNRPA QKI HDGFL2 PML HDLBP	1.30e-04	637	122	13	int:SNRNP40
Interaction	SNRNP27 interactions	MECP2 UBR5 TPX2 CDC5L QKI HDGFL2 HDLBP	1.31e-04	184	122	7	int:SNRNP27
Interaction	CAAP1 interactions	MECP2 UBR5 DDX23 SNRPA	1.31e-04	43	122	4	int:CAAP1
Interaction	GOLGA2 interactions	RNF169 HIVEP1 HYOU1 CCDC185 UBXN6 ASAP3 DAXX ZNF318 ARID5A FAM161A TPX2 EBAG9 CDC5L HDLBP	1.42e-04	733	122	14	int:GOLGA2
Interaction	CEBPB interactions	VAPB RARB HYOU1 ZC3H15 DAXX TFCP2 ARCN1 RTF1 CCDC47 RRS1 UBP1 NFIL3 ARHGEF1 TPX2 DDX23 CDC5L QKI TIMM44 HDGFL2 HSPA6 HELLS	1.47e-04	1443	122	21	int:CEBPB
Interaction	THOC5 interactions	ZC3H15 MECP2 TJP1 DDX23 SNRPA HDLBP	1.47e-04	131	122	6	int:THOC5
Interaction	PRMT1 interactions	ZC3H15 CEP162 KHDRBS2 DAXX MECP2 GRIP1 KHDRBS3 OTUD4 DDX23 CDC5L GRHL3 SNRPA QKI RBM34 PML HDLBP	1.54e-04	929	122	16	int:PRMT1
Interaction	SRPK1 interactions	NOC2L ARCN1 RRS1 DDX23 CDC5L SNRPA CCDC86 HDGFL2 RBM34 HDLBP HELLS	1.54e-04	477	122	11	int:SRPK1
Interaction	EFTUD2 interactions	ZC3H15 CC2D1A MECP2 ARCN1 RTF1 ARRB1 PPP2R5D UBR5 TJP1 CCDC47 ARHGEF1 DIAPH1 DDX23 CDC5L SNRPA TIMM44 CCDC86 HDGFL2 HSPA6 HDLBP HELLS	1.55e-04	1449	122	21	int:EFTUD2
Interaction	DNAJC17 interactions	HYOU1 DDX23 CDC5L HDGFL2 PML HELLS	1.66e-04	134	122	6	int:DNAJC17
Interaction	HNRNPU interactions	RNF169 RARA NOC2L UBXN6 MECP2 TFCP2 ARRB1 MRPL16 UBR5 RRS1 TPX2 DDX23 CDC5L SNRPA CCDC86 RBM34 PML	1.66e-04	1035	122	17	int:HNRNPU
Interaction	ARHGEF5 interactions	VAPB UBXN6 MECP2 SNRPA CCDC86	1.67e-04	85	122	5	int:ARHGEF5
Interaction	HELLS interactions	UBXN6 TFCP2L1 TPX2 DDX23 CDC5L PML HELLS	1.70e-04	192	122	7	int:HELLS
Interaction	PRKACB interactions	VAPB MYH1 MYH2 MYH4 MYH6 TPRKB DDX23	1.75e-04	193	122	7	int:PRKACB
Interaction	MYO1D interactions	UBXN6 TFCP2 USP20 DNAI2 TPX2 HSPA6 PML	1.81e-04	194	122	7	int:MYO1D
Interaction	SLX4 interactions	RNF169 ATXN7L1 DAXX CHD8 ZNF318 ODF2 UBR5 TPX2 HSPA6 PML HDLBP HELLS	1.85e-04	572	122	12	int:SLX4
Interaction	CDC5L interactions	CCDC185 CHD8 MECP2 ARCN1 UBR5 ARHGEF1 TPX2 DIAPH1 DDX23 CDC5L SNRPA HSPA6 PML HDLBP HELLS	2.06e-04	855	122	15	int:CDC5L
Interaction	ZRANB2 interactions	MECP2 RTF1 OSBP ARRB1 DDX23 CCDC86 HDGFL2	2.12e-04	199	122	7	int:ZRANB2
Interaction	ZC3H10 interactions	HIVEP1 NOC2L ARID5A RRS1 SNRPA QKI RBM34	2.18e-04	200	122	7	int:ZC3H10
Interaction	SCAF4 interactions	VAPB MECP2 RRS1 SNRPA MED27 HDLBP	2.19e-04	141	122	6	int:SCAF4
Interaction	ADRB1 interactions	GPRASP1 USP20 ARRB1	2.29e-04	20	122	3	int:ADRB1
Interaction	DDX43 interactions	KHDRBS2 DCAF4 HDLBP	2.29e-04	20	122	3	int:DDX43
Interaction	SUGP1 interactions	MECP2 TJP1 DDX23 SNRPA TIMM44 PML	2.36e-04	143	122	6	int:SUGP1
Interaction	RBFOX1 interactions	NOC2L MECP2 ARID5A CELF3 QKI	2.42e-04	92	122	5	int:RBFOX1
Interaction	FBXO38 interactions	RNF169 HIVEP1 ATXN7L1 CHD8 UBR5 HSPA6	2.55e-04	145	122	6	int:FBXO38
Interaction	NR3C1 interactions	MYH2 HIVEP1 RARB HYOU1 DAXX GRIP1 OSBP ARRB1 CCDC47 UBP1 OTUD4 LMOD1 C3 RBM34 PML HELLS	2.62e-04	974	122	16	int:NR3C1
Interaction	KHDRBS3 interactions	KHDRBS2 MECP2 KHDRBS3 MARK4 SNRPA	2.67e-04	94	122	5	int:KHDRBS3
Interaction	CLINT1 interactions	MYH7 CC2D1A ODF2 NT5DC3 CDC5L PML HDLBP	2.69e-04	207	122	7	int:CLINT1
Interaction	RBMS1 interactions	TFCP2 RRS1 OTUD4 QKI TIMM44 DCAF4 HDLBP	2.69e-04	207	122	7	int:RBMS1
Interaction	EP300 interactions	RARA RARB ASCC1 DAXX MECP2 ARCN1 RTF1 GRIP1 OSBP ARRB1 PIK3R1 TPX2 DDX23 C3 CDC5L SNRPA TIMM44 DCAF4 PML HELLS	2.77e-04	1401	122	20	int:EP300
Interaction	NEIL1 interactions	NOC2L DHX37 DAXX MRPL16 RRS1 CDC5L CCDC86 RBM34	2.80e-04	276	122	8	int:NEIL1
Interaction	SFSWAP interactions	MECP2 UBR5 TPX2 DDX23 HDLBP	2.95e-04	96	122	5	int:SFSWAP
Interaction	ROS1 interactions	VAPB HYOU1 ARCN1 TIMM44 HDLBP	2.95e-04	96	122	5	int:ROS1
Interaction	RARRES1 interactions	ZNF318 KHDRBS3 TPX2	3.06e-04	22	122	3	int:RARRES1
Interaction	KRT40 interactions	MYH1 MYH2 MYH4 MYH7 CCDC185 UACA IFFO1 ARID5A MARK4 TNNT1	3.12e-04	434	122	10	int:KRT40
Interaction	CCDC102B interactions	UACA MARK1 TJP1 FAM161A CCDC86 HDLBP	3.17e-04	151	122	6	int:CCDC102B
Interaction	TNNI1 interactions	MYH6 MYH7 USP20 TNNT1	3.20e-04	54	122	4	int:TNNI1
Interaction	CENPC interactions	DAXX DDX23 CDC5L DCAF4 RBM34	3.24e-04	98	122	5	int:CENPC
Interaction	RPL13 interactions	NOC2L DHX37 DAXX MECP2 TFCP2 USP20 ARRB1 MRPL16 RRS1 CDC5L HDGFL2 RBM34 PML	3.25e-04	700	122	13	int:RPL13
Interaction	MECOM interactions	MYH1 MYH2 MYH4 MYH7 TJP1 RRS1 CDC5L TIMM44 HELLS	3.34e-04	358	122	9	int:MECOM
Interaction	KLHL20 interactions	NOC2L CC2D1A ARHGEF11 MECP2 USP20 HDGFL2 PML	3.48e-04	216	122	7	int:KLHL20
Interaction	SERPINC1 interactions	HYOU1 USP20 LMOD1 C3	3.68e-04	56	122	4	int:SERPINC1
Interaction	GNA12 interactions	ARHGEF11 MECP2 TFCP2 ARHGEF1	3.68e-04	56	122	4	int:GNA12
Interaction	ABTB2 interactions	MYH1 MYH2 MYH4 MYH6 ZNF318	3.73e-04	101	122	5	int:ABTB2
Interaction	THOC2 interactions	ZC3H15 MECP2 CCDC47 DDX23 CDC5L PML HDLBP	3.79e-04	219	122	7	int:THOC2
Interaction	RAC3 interactions	VAPB UACA RALGAPB CC2D1A ARMCX3 C1orf226 MRPL16 CCDC47 PIK3R1 DIAPH1 DAAM1 HSPA6	3.80e-04	619	122	12	int:RAC3
Interaction	IFI16 interactions	UACA NOC2L ZC3H15 DHX37 KHDRBS3 TJP1 RRS1 OTUD4 DDX23 CDC5L CCDC86 RBM34 PML	3.93e-04	714	122	13	int:IFI16
Interaction	AXL interactions	VAPB MYH2 HYOU1 UBXN6 TJP1 RRS1 PIK3R1 TIMM44 HSPA6	4.16e-04	369	122	9	int:AXL
Interaction	STK4 interactions	VAPB MYH1 MYH2 MYH6 MYH7 DAXX	4.18e-04	159	122	6	int:STK4
Interaction	CWC25 interactions	LAMC3 TPX2 DDX23 CDC5L	4.21e-04	58	122	4	int:CWC25
Cytoband	Ensembl 112 genes in cytogenetic band chrXq22	GPRASP1 TCEAL3 TCEAL2 ARMCX3 TCEAL6	1.05e-04	172	123	5	chrXq22
Cytoband	Xq22.1	GPRASP1 ARMCX3 TCEAL6	2.14e-04	43	123	3	Xq22.1
Cytoband	19p13.3-p13.2	C3 TIMM44	6.34e-04	14	123	2	19p13.3-p13.2
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH4 MYH6 MYH7	3.57e-09	15	77	5	1098
GeneFamily	Transcription elongation factor A like family	TCEAL3 TCEAL2 TCEAL6	6.13e-06	9	77	3	1216
GeneFamily	Signal transduction and activation of RNA metabolism family	KHDRBS2 KHDRBS3	5.36e-05	3	77	2	1275
GeneFamily	Ankyrin repeat domain containing\|POTE ankyrin domain containing	POTED POTEC	1.35e-03	13	77	2	685
GeneFamily	Heat shock 70kDa proteins	HYOU1 HSPA6	2.34e-03	17	77	2	583
Coexpression	GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP	NOC2L DAXX ARID5A RRS1 NFIL3 DIAPH1 SNRPA CCDC86	4.86e-06	200	123	8	M8650
Coexpression	SMID_BREAST_CANCER_BASAL_UP	TCEAL2 SIM1 TFCP2L1 KHDRBS3 NFIL3 TPX2 PRDM13 CDC5L QKI TIMM44 HSPA6 PML HELLS	1.46e-05	662	123	13	M8124
Drug	fast white	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	8.92e-08	42	121	6	CID000024008
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; HL60; HT_HG-U133A	RARA CHD8 ARHGEF11 USP20 PPP2R5D ARHGEF1 C3 TNNT1 PML	1.16e-06	198	121	9	1299_DN
Drug	hexadeca-10,12-dien-1-ol	RARB TFCP2 TFCP2L1 UBP1 GRHL3	6.17e-06	49	121	5	CID000013850
Drug	SM-2	MYH1 MYH2 MYH4 MYH6 MYH7 LMOD1	7.07e-06	87	121	6	CID000486033
Drug	formycin triphosphate	MYH1 MYH2 MYH4 MYH6 MYH7	7.54e-06	51	121	5	CID000122274
Drug	Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A	MYH7 ASAP3 MYRIP NT5DC3 PIK3IP1 MARK4 OTUD4 C3	1.14e-05	199	121	8	5995_UP
Drug	purealin	MYH1 MYH2 MYH4 MYH6 MYH7	1.43e-05	58	121	5	CID006419303
Drug	Ro 8-8717	RARA RARB	2.80e-05	2	121	2	CID006438148
Drug	Tamibarotene	RARA RARB	2.80e-05	2	121	2	DB04942
Drug	B0683	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	3.85e-05	117	121	6	CID006398969
Drug	oxovanadium	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	4.43e-05	120	121	6	CID000024411
Drug	nocodazole	MYH1 MYH2 MYH4 MYH6 MYH7 MYRIP CPOX SIM1 KMT2E PPP2R5D NFIL3	4.90e-05	477	121	11	CID000004122
Drug	AC1L1DMQ	RARA RARB GDF10	5.11e-05	14	121	3	CID000002418
Drug	NSC339663	MYH1 MYH2 MYH4 MYH6 MYH7 ARHGEF11 ARRB1 PIK3R1	5.84e-05	250	121	8	CID000003892
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; PC3; HT_HG-U133A	ATXN7L1 IFFO1 CEP162 ASAP3 ODF2 PIK3R1 C3	7.39e-05	191	121	7	3803_DN
Drug	Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A	ARHGEF11 ARID5A PIK3IP1 RTF1 RNF220 TIMM44 HDLBP	7.63e-05	192	121	7	1623_DN
Drug	Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA	CEP162 CC2D1A ARHGEF11 NT5DC3 QKI DCAF4 PML	7.89e-05	193	121	7	948_UP
Drug	colchicine; Down 200; 1uM; SKMEL5; HG-U133A	HYOU1 ZC3H15 ARHGEF11 ARRB1 PIK3R1 EBAG9 PML	8.41e-05	195	121	7	630_DN
Drug	Azapropazone [13539-59-8]; Down 200; 13.4uM; PC3; HT_HG-U133A	RARA ASAP3 CC2D1A ODF2 MECP2 QKI PML	8.69e-05	196	121	7	7277_DN
Drug	aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A	GPRASP1 RARA MYRIP ARHGEF11 MARK4 DNAI2 QKI	8.97e-05	197	121	7	6964_UP
Drug	Cefazolin sodium salt [27164-46-1]; Up 200; 8.4uM; PC3; HT_HG-U133A	MYH2 RARA MARK1 HKDC1 ODF2 C3 PML	8.97e-05	197	121	7	3686_UP
Drug	Metoclopramide monohydrochloride [7232-21-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	VAPB ARHGEF11 ARID5A PIK3IP1 DIAPH1 CDC5L PML	8.97e-05	197	121	7	2353_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A	UBXN6 CC2D1A ODF2 NT5DC3 MECP2 USP20 PPP2R5D	8.97e-05	197	121	7	4814_DN
Drug	Nimesulide [51803-78-2]; Down 200; 13uM; MCF7; HT_HG-U133A	UBXN6 CC2D1A ZNF318 USP20 CDC5L RBM34 PML	8.97e-05	197	121	7	2275_DN
Drug	Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; MCF7; HT_HG-U133A	CC2D1A ZNF318 NT5DC3 ARHGEF1 MARK4 QKI PML	9.26e-05	198	121	7	7013_UP
Drug	Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A	CEP162 ASAP3 ZNF318 MECP2 TFCP2L1 QKI RBM34	9.26e-05	198	121	7	5867_UP
Drug	Ketorolac tromethamine [74103-07-4]; Up 200; 10.6uM; HL60; HT_HG-U133A	GPRASP1 RARB ASAP3 CASP5 KHDRBS3 TJP1 DNAI2	9.26e-05	198	121	7	3110_UP
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; MCF7; HT_HG-U133A	GPRASP1 CEP162 UBXN6 CC2D1A PIK3IP1 QKI PML	9.26e-05	198	121	7	1688_UP
Drug	Vidarabine [5536-17-4]; Up 200; 15uM; MCF7; HT_HG-U133A	MYH2 ASAP3 CASP5 ZNF318 ARRB1 MARK4 PML	9.26e-05	198	121	7	7203_UP
Drug	Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A	STK17A UBXN6 ASAP3 MARK4 DIAPH1 QKI RBM34	9.26e-05	198	121	7	1489_UP
Drug	AC1NRBPQ	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	9.27e-05	137	121	6	CID005288569
Drug	Hexamethonium dibromide dihydrate [55-97-0]; Up 200; 10uM; MCF7; HT_HG-U133A	GPRASP1 ATXN7L1 STK17A ASAP3 DNAI2 DCAF4 PML	9.55e-05	199	121	7	1482_UP
Drug	Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RARA CEP162 TCEAL2 LAMC3 PIK3IP1 ARHGEF1 C3	9.85e-05	200	121	7	6837_UP
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.14e-10	10	116	5	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	6.67e-10	12	116	5	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	6.67e-10	12	116	5	DOID:2106 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	1.08e-09	13	116	5	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	2.50e-09	15	116	5	DOID:0050646 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7 TNNT1	3.77e-07	71	116	6	DOID:0050700 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	1.29e-06	48	116	5	DOID:423 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH4 MYH6 MYH7	1.64e-05	80	116	5	DOID:12930 (implicated_via_orthology)
Disease	diffuse idiopathic skeletal hyperostosis	PIK3R1 NFIL3 CDC5L	2.60e-05	15	116	3	EFO_0007236
Disease	Neuralgia-Neuritis, Sciatic Nerve	RARA RARB	9.15e-05	4	116	2	C0751924
Disease	Sciatic Nerve Palsy	RARA RARB	9.15e-05	4	116	2	C0751925
Disease	Cardiomyopathy, Familial Hypertrophic, 1 (disorder)	MYH6 MYH7	9.15e-05	4	116	2	C3495498
Disease	Hypertrophic cardiomyopathy 1	MYH6 MYH7	9.15e-05	4	116	2	cv:C3495498
Disease	Sciatic Neuropathy	RARA RARB	9.15e-05	4	116	2	C0149940
Disease	Caveolinopathy	MYH6 MYH7	9.15e-05	4	116	2	cv:C5679790
Disease	CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	MYH6 MYH7	9.15e-05	4	116	2	192600
Disease	Lesion of Sciatic Nerve	RARA RARB	9.15e-05	4	116	2	C0154748
Disease	Sciatic Neuritis	RARA RARB	9.15e-05	4	116	2	C0242013
Disease	visual impairment and progressive phthisis bulbi (implicated_via_orthology)	MARK1 MARK4	9.15e-05	4	116	2	DOID:0070356 (implicated_via_orthology)
Disease	Limb-girdle muscular dystrophy	MYH6 MYH7 SGCB	1.44e-04	26	116	3	cv:C0686353
Disease	Neoplasms, Therapy-Associated	RARA PML	2.27e-04	6	116	2	C0086696
Disease	Neoplasms, Second Primary	RARA PML	2.27e-04	6	116	2	C0085183
Disease	Treatment related secondary malignancy	RARA PML	2.27e-04	6	116	2	C0877578
Disease	Heart Failure, Diastolic	MYH6 MYH7 PIK3IP1	2.96e-04	33	116	3	C1135196
Disease	Idiopathic hypertrophic subaortic stenosis	MYH6 MYH7	3.18e-04	7	116	2	C0700053
Disease	Obstructive asymmetric septal hypertrophy	MYH6 MYH7	3.18e-04	7	116	2	C0597124
Disease	acute promyelocytic leukemia (is_implicated_in)	RARA PML	3.18e-04	7	116	2	DOID:0060318 (is_implicated_in)
Disease	oppositional defiant disorder measurement	HIVEP1 RARB TPX2	3.85e-04	36	116	3	EFO_0007679
Disease	P wave terminal force measurement	MYH6 ALPK3	4.22e-04	8	116	2	EFO_0008379
Disease	Cardiomyopathy, Hypertrophic, Familial	MYH6 MYH7	5.42e-04	9	116	2	C0949658
Disease	vascular endothelial function measurement	RARB PLEKHD1 DNAI2 PRDM13	6.40e-04	99	116	4	EFO_0803369
Disease	Muscular dystrophy, limb-girdle, autosomal dominant	MYH6 MYH7	6.75e-04	10	116	2	cv:C5675009
Disease	Cardiomyopathy, Dilated	MYH6 MYH7 SGCB	9.00e-04	48	116	3	C0007193
Disease	amyotrophic lateral sclerosis (biomarker_via_orthology)	RARA C3	1.16e-03	13	116	2	DOID:332 (biomarker_via_orthology)
Disease	Hypertrophic Cardiomyopathy	MYH6 MYH7 ALPK3	1.48e-03	57	116	3	C0007194
Disease	Intellectual Disability	CHD8 KMT2E MECP2 PPP2R5D CCDC47 DIAPH1 QKI	1.98e-03	447	116	7	C3714756
Disease	Muscle hypotonia	ASCC1 MECP2	2.00e-03	17	116	2	C0026827
Disease	delta-5 desaturase measurement, response to polyunsaturated fatty acid supplementation	UBXN6 HDGFL2	2.00e-03	17	116	2	EFO_0007764, EFO_0009131
Disease	lean mass-adjusted fat body mass	PIK3R1 CDC5L	2.25e-03	18	116	2	EFO_0009890
Disease	cartilage thickness measurement	PIK3R1 CDC5L	2.25e-03	18	116	2	EFO_0007873
Disease	intrinsic cardiomyopathy (implicated_via_orthology)	DAAM1 TNNT1	3.06e-03	21	116	2	DOID:0060036 (implicated_via_orthology)
Disease	Bronchiectasis	PIK3R1 DNAI2	3.36e-03	22	116	2	C0006267
Disease	Primary familial hypertrophic cardiomyopathy	MYH6 MYH7	3.36e-03	22	116	2	cv:C0949658
Disease	Autistic Disorder	MARK1 CHD8 KMT2E MECP2 HDLBP	3.77e-03	261	116	5	C0004352

Protein segments in the cluster

Peptide	Gene	Start	Entry
RAGESEEQRKMRKRI	CCDC185	491	Q8N715
EEDRRKKIARMGFNA	DCAF4	111	Q8WV16
RKKVMGNRRSDEPAK	ARHGEF1	246	Q92888
TERPKKAKEERRMDQ	ARID5A	176	Q03989
KFADTEKERGLRRMQ	CELF3	171	Q5SZQ8
AKMAKLEKERDRARV	ASAP3	156	Q8TDY4
KREQMKIEAAERGDR	CHD8	1761	Q9HCK8
RKQAIRDAERVKEMK	CDC5L	521	Q99459
MKERQERKLAKDFAR	CCDC86	271	Q9H6F5
RKAQADKGTQEDRRM	ALPK3	886	Q96L96
KGREEMKRSRKAENV	ARHGEF11	616	O15085
RSVQLTEKRMDKVGK	C3	671	P01024
EKQKGRFRMKEREEM	PPP2R5D	491	Q14738
IVGKRGDTRKKIEME	ASCC1	101	Q8N9N2
RETEEKMRRAKLAKE	DIAPH1	1156	O60610
EARHREMRLKEKGKA	DNAI2	511	Q9GZS0
MLQDKSEEGERKKRR	DAXX	381	Q9UER7
RLTRGRKQNKEKMAE	ARMCX3	26	Q9UH62
FARQRLKGMKDDKEE	ARRB1	391	P49407
KKQQEGRAMATLDRK	ATXN7L1	21	Q9ULK2
REKRAAEQQRKKMEK	EBAG9	181	O00559
MDRQARRLGGRKDKE	RCOR2	186	Q8IZ40
MSKRKRKRSVQEGEN	RBM34	6	P42696
KGSRRRMDTEERKDK	OTUD4	501	Q01804
VGMSKESVRNDRNKK	RARA	151	P10276
VGMSKESVRNDRNKK	RARB	151	P10826
KGSMRDKKKEEQNRG	QKI	126	Q96PU8
RSRNEALRVKKKMEG	MYH7	1606	P12883
KRNAESVKGMRKSER	MYH7	1831	P12883
EKPVMRKKRGREDES	HELLS	121	Q9NRZ9
QRGQLGRDEKRVDMK	IGDCC3	701	Q8IVU1
KRDKNVREMKESVNR	BAIAP2L2	146	Q6UXY1
GRKDRRKKGQEVFMA	GDF10	336	P55107
SRREEKKRAEKERIM	CCDC47	431	Q96A33
ERRNTDTRKEGEKMK	LMOD1	226	P29536
KKREAEFQKMRRDLE	MYH2	1171	Q9UKX2
RRKREFIPDEKKDAM	NFIL3	61	Q16649
QIAERKRKMTREERK	KMT2E	566	Q8IZD2
NEMKREGKFREKRIK	L1RE1	126	Q9UN81
KRREKKERMGEQEKT	GOLGA6L7	526	A0A1B0GV03
SRNDAIRLKKKMEGD	MYH1	1611	P12882
KKERVLRKEEAARMS	ERC2	191	O15083
KDGMRNKETLEGREK	MED27	36	Q6P2C8
GISQRVRMNSKEKKD	PIK3IP1	151	Q96FE7
KFKREGNEKEIQRIM	PIK3R1	511	P27986
RMLEEERKKRKQFQD	DDX23	186	Q9BUQ8
RKMADRKDEDRKQFK	NOC2L	651	Q9Y3T9
EKQRLSRKKREAEAM	OSBP	741	P22059
RKRSEGFSMDRKVEK	HDGFL2	451	Q7Z4V5
MGGRKRERKAAVEED	IFFO1	361	Q0D2I5
LRDTDMNKRDKQKRT	POTEB3	161	A0JP26
RERKMRKAKENSEES	DAAM1	1016	Q9Y4D1
KQKPARKRRMVEEIG	HYOU1	686	Q9Y4L1
DKGAERKMRDDERKQ	GRHL3	401	Q8TE85
MAEDSGKKKRRKNFE	CASP5	1	P51878
QLMEKRETEGKDSKR	GJA9	366	P57773
KAMGAKVNDFLRRKE	C1orf226	56	A1L170
RCVDMQRSRHEKKKG	DDX11L8	286	A8MPP1
AKSKGDQRKARMHER	CC2D1A	366	Q6P1N0
GREEMSAKRAKKDVL	CEP162	1126	Q5TB80
HGRMKEKEARAKFRQ	MARK1	151	Q9P0L2
GRMKEKEARAKFRQI	MARK4	151	Q96L34
SMRDKAKEEELRKSG	KHDRBS2	106	Q5VWX1
GSMRDKAKEEELRKS	KHDRBS3	101	O75525
RDKIPEEDRRKMQDK	HSPA6	561	P17066
RGREQAVRKSEKERM	FAM161A	521	Q3B820
DVGRKSVTLRKMKQE	GRIP1	976	Q9Y3R0
KRKSEMLQKAARGRE	FMR1NB	236	Q8N0W7
VEEMRKFKKSRARAK	DHX37	511	Q8IY37
KKKVRMVRGELVDES	PRDM13	46	Q9H4Q3
EEAAKQMRSRGKVLK	CPOX	216	P36551
QEREAKAEMRRKAKE	ARCN1	151	P48444
MKGLKAKFRQIEDDR	OLFM3	121	Q96PB7
GERQMAKRFLEERKE	ODF2	146	Q5BJF6
LRDTDMNKRDKQKRT	POTEC	161	B2RU33
MVIKRPGRKRKAEAD	MECP2	246	P51608
LRDTDMNKRDKEKRT	POTED	161	Q86YR6
RARAMTKEEAKTKAR	GPRASP1	376	Q5JY77
SRGTLEKMRKDQEER	MRPL16	191	Q9NX20
AMEELKAEREKRKNR	RTF1	281	Q92541
ETRIRAMDKDAKKRI	RTKN2	341	Q8IZC4
ERERQAKLAEEKMRK	TNNT1	121	P13805
SEMAEASRKKKENRR	TMCO4	171	Q5TGY1
RRFRAEMEKGLAKDT	HKDC1	41	Q2TB90
MEGKRQLEKRDFGKR	NCKAP5	1	O14513
SMGRREAKLDTENKR	NPHP3	111	Q7Z494
NDKRRPFRKMNEKGV	NT5DC3	336	Q86UY8
RKVIKMESEEGKEAR	PML	486	P29590
MKEKSKNAARTRREK	SIM1	1	P81133
SRNDALRIKKKMEGD	MYH4	1611	Q9Y623
TETGKRKMDEQKKRD	RNF169	216	Q8NCN4
NARIGKMKRRKQDEG	RNF220	316	Q5VTB9
KMKRRKQDEGQREGS	RNF220	321	Q5VTB9
GPVKKSMREKAVERR	SGCB	16	Q16585
KGADRKQKTDREKME	TFCP2L1	221	Q9NZI6
EQEKKVRMDLERAKR	MYH6	1041	P13533
NKKREAEFQKMRRDL	MYH6	1166	P13533
EQKRNAESVKGMRKS	MYH6	1831	P13533
AESVKGMRKSERRIK	MYH6	1836	P13533
EFAAKFMRKRRKGQD	STK17A	86	Q9UEE5
AEGKNTKRREIKMNV	C10orf120	231	Q5SQS8
MLRAQKSRDGDKEDK	TCERG1L	301	Q5VWI1
VLRTKAMREKEEQRG	UBXN6	316	Q9BZV1
KGADRKQKTDREKME	TFCP2	241	Q12800
SKVRNKEKEERMRAD	PLEKHD1	381	A6NEE1
DQEEAAKRRKMSQKG	RRS1	296	Q15050
VSRAQEELRKKQKMG	TCEAL6	146	Q6IPX3
MLREEAAQKRKGKES	ZNF808	1	Q8N4W9
FDNMARVEDKRRKSK	TCEAL2	171	Q9H3H9
MEAERRRQAEKPKKG	PROP1	1	O75360
LAKVKVMVDSGDRKR	RALGAPB	791	Q86X10
VSRAQEELRKKQKMG	TCEAL3	146	Q969E4
EAGRAISEKERMKDR	USP20	316	Q9Y2K6
EREKKGRKVTEMEGQ	UACA	601	Q9BZF9
RSKGKLKMVVQRDER	TJP1	251	Q07157
DRKQKTDREKMEKRT	UBP1	241	Q9NZI7
EMKESIKKFRDEARR	TIMM44	76	O43615
ENKQFKEEDGLRMRK	VAPB	186	O95292
RGKAIRKIMDEFKVD	HDLBP	1146	Q00341
EQDMERRKADFKAGK	ZC3H15	271	Q8WU90
KQQGEMLRKKRREKD	ZNF318	921	Q5VUA4
PQIRKRRKMKSVGDD	HIVEP1	1026	P15822
KMKGTFVERDRKREK	SNRPA	96	P09012
KESKFRREMEKLRNQ	UBR5	2221	O95071
KDVKNAGDLRRKAME	TPRKB	21	Q9Y3C4
RGCDKRKVMEEDKRR	TTLL13	421	A6NNM8
KRAKERQELEKRMAE	TPX2	666	Q9ULW0
ADTRKKTKQAERMLG	LAMC3	1371	Q9Y6N6
NRTKERKGTTKDLME	MYRIP	836	Q8NFW9